Formulation of green synthesized silver nanoparticles highlights their anticancer potential, indicating a promising therapy for tumor development.
Silver nanoparticles (AgNPs) synthesized using green methods, particularly utilizing plant extracts, have emerged as promising candidates for anticancer therapy. This paper presents the formulation and comprehensive evaluation of green synthesized plant-based silver nanoparticles for their therapeutic potential in cancer treatment. The green synthesis approach offers advantages such as eco-friendliness, cost-effectiveness and scalability, making it an attractive option for nanoparticle synthesis. During the synthesis process, plant extracts act as reducing and stabilizing agents, leading to the creation of biocompatible nanoparticles with improved anticancer capabilities. The formulation process involves optimizing synthesis parameters such as extract concentration, reaction time and temperature to achieve nanoparticles with desirable characteristics. The results show that these nanoparticles effectively inhibit cancer cell growth, trigger apoptosis and reduce tumor development. Overall, the formulation and evaluation of green synthesized plant-based silver nanoparticles offer promising insights into their therapeutic prospective for anticancer applications, highlighting their potential as novel and sustainable nanotherapeutics in the fight against cancer.
No takes yet. Share an insight, caveat, or question.
Nripendra Singh (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: